Vernalis, Servier sign second cancer collaboration
Vernalis PLC and Servier SA have entered into a second three-year collaboration to discover cancer therapeutics.
- Drug Discovery Tools
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.